Analytical exoglycosidases are transitioning from being largely academic tools to being suitable for glycan analytics in biopharmaceutical manufacturing.
Ian Walsh
Advertisement
Ian Walsh is an associate staff scientist at Bioprocessing Technology Institute, Agency for Science, Technology and Research.
Articles by Ian Walsh
Advertisement
Latest Updated Articles
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic DrugsPublished: October 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Analytics, Automation, and Quality Driving the Next Era of Drug Development
3
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
4
Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress
5
